|
GB202102297D0
|
|
Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells
|
|
GB202017024D0
|
|
Process for producing enveloped viruses
|
|
WO2021032855A1
|
|
Culture medium for haematopoietic induction
|
|
GB202012306D0
|
|
Culture medium for haematopoietic induction
|
|
GB202006474D0
|
|
Method of treatment of cancer or tumour
|
|
GB202005617D0
|
|
Improved t cell manufacturing process
|
|
GB202000546D0
|
|
Method of treatment of cancer or tumour
|
|
GB201915375D0
|
|
HLA-independent t cell receptors
|
|
GB201915367D0
|
|
T cell receptors and modified t cells
|
|
GB201911957D0
|
|
Methods of producing haemogenic progenitor cells from pluripotent stem cells
|
|
GB201911958D0
|
|
Methods of t cell production
|
|
GB201911953D0
|
|
T cell production fram RAG inacivated iPSCs
|
|
GB201911955D0
|
|
Culture medium for haematopoietic induction
|
|
GB201911954D0
|
|
Lentiviral transduction methods
|
|
GB201820444D0
|
|
Marker for T cell expansion
|
|
GB201819540D0
|
|
T cell modification
|
|
GB201815011D0
|
|
Viral assay method
|
|
GB201713078D0
|
|
T Cell Modification
|
|
MX2018012265A
|
|
T cell receptors.
|
|
EP3440106A1
|
|
T cell receptors
|
